Plaquenil may be prescribed for:

• A. Conjunctivitis
• B. Glaucoma
• C. Cataracts
• D. Systemic lupus erythematosus

Answer: (D)

Plaquenil, or hydroxychloroquine, is an antimalarial drug with immunomodulatory effects that make it useful as a long-term treatment for autoimmune diseases, especially systemic lupus erythematosus. It helps control inflammation and can reduce disease activity and flare-ups in lupus. This makes it a standard option for managing lupus-related symptoms and improving overall disease control.

Conjunctivitis is typically treated with oplossingen targeting surface inflammation or infection (like antibiotics or antiviral drops) and isn’t managed with immunomodulatory systemic therapy. Glaucoma involves lowering intraocular pressure to prevent nerve damage, usually with eye drops, lasers, or surgery. Cataracts are a clouding of the lens requiring surgical removal. None of these are treated with Plaquenil as a primary therapy, which is why systemic lupus erythematosus is the correct context for its prescription.